Licit substance abuse during pregnancy and its effect on the foetus

Review of Clinical Pharmacology and Pharmacokinetics, International Edition

Volumn 15, Issue 1, 2001, Pages 21-32

  Deltsidou, A ^a   Lykeridou, K ^a   Plessas, S T ^a  

^a NONE   (Greece)

Author keywords

Addiction; Dependence; Fetal alcohol syndrome FAS syndrome; Substance abuse; Withdrawal syndrome

Indexed keywords

ALCOHOL; AMPHETAMINE; ANXIOLYTIC AGENT; CAFFEINE; CANNABIS; COCAINE; HYPNOTIC AGENT; ILLICIT DRUG; OPIATE; PSYCHEDELIC AGENT; PSYCHOTROPIC AGENT;

BLOOD PLACENTA BARRIER; CIGARETTE SMOKING; CONCENTRATION (PARAMETERS); DEVELOPMENTAL DISORDER; FETAL ALCOHOL SYNDROME; FETOTOXICITY; GROWTH RETARDATION; HUMAN; LOW BIRTH WEIGHT; MENTAL DEFICIENCY; PREGNANCY; PRENATAL EXPOSURE; REVIEW; SAFETY; SUBSTANCE ABUSE; TOBACCO;

EID: 0035099110     PISSN: 10116583     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (96)

1. Biology of addiction
2. Newborn infants with drug withdrawal symptoms
3. Neonatal drug withdrawal syndromes
4. Effects of life-style on reproduction
5. Drugs in pregnancy and lactation
6. Caffeine content of common beverages
7. No association between coffee consumption and adverse outcomes in pregnancy
8. Relation of caffeine intake during pregnancy to intrauterine retardation and preterm birth
9. A clinical perspective of the fetal alcohol syndrome
10. Strategies for prevention of fetal alcohol effects
11. Fetal alcohol syndrome: Hearing, speech, language, and vestibular disorders
12. The fetal alcohol syndrome in mice. Maternal variables
13. Fetal alcohol syndrome
14. Fetal effects of maternal use
15. Recognition of the fetal alcohol syndrome in early infancy
16. In vitro model for evaluation of medicines phototoxic activity
17. Early neurobehavioral assessment of children prenatally exposed to alcohol
18. Cocaine and the fetus: Methodological issue and neurological correlates
19. Fetal alcohol syndrome: A description of oral motor, articulatory, short-term memory, grammatical, and semantic abilities
20. Neuropsychological deficits in fetal alcohol syndrome and fetal alcohol effects
21. Neonatal effects of alcohol use
22. The impact of prenatal drug exposure on the neonate
23. The effects of prenatal alcohol exposure on postnatal development of the brainstem auditory evoked potential in the rat
24. Sensorineural hearing loss in children-nongenetic
25. Correlation between craniofacial, hearing, and language disorders in the Fetal Alcohol Syndrome
26. Hearing, speech, language, vestibular and dentofacial disorders in the Fetal Alcohol Syndrome (FAS)
27. Hearing disorders in children with Fetal Alcohol Syndrome: Findings from case reports
28. Effects on the child of alcohol abuse during pregnancy
29. Prenatal exposure to alcohol: Effect on infant growth and morphologic characteristics
30. The effects of timing and duration of alcohol exposure on development of the fetal brain
31. Ethanol-induced acceleration of preimplantation embryonic development
32. Fetal alcohol syndrome in Saskatchewan: Unchanged incidence in a 20-year period
33. Fetal alcohol syndrome
34. National survey results on drug use
35. Inhalant abuse in pregnancy
36. CNS depressant effects of volatile organic solvents
37. Major malformations in infants born to women who worked in laboratories while pregnant
38. Congenital defects of the central nervous system and occupational factors during pregnancy
39. Chemical exposures at work in early pregnancy and congenital defect: A case referent study
40. Oral clefts and organic solvent exposure during pregnancy
41. Maternal occupational exposure and congenital malformations
42. Risk factors for ventricular septal defect in Finland
43. Exposure to organic solvents and hypertensive disorders in pregnancy
44. Effects of parental exposure to solvents on pregnancy outcome
45. Fetal solvents syndrome
46. Toluene embryopathy: Two new cases
47. Toluene abuse during pregnancy: Obstetric complications and perinatal outcomes
48. Toluene embryopathy: Clinical delineation and developmental follow-up
49. Toluene embryopathy: Delineation of the phenotype and comparison with fetal alcohol syndrome
50. Smoking and pregnancy
51. Smoking during pregnancy: Prevalence, effects, and intervention strategies
52. Social and illicit drug use in pregnancy
53. A preliminary report on cigarette smoking and the incidence of prematurity
54. Fetal toxicology of environmental tobacco smoke
55. Absorption and metabolism of nicotine from cigarettes
56. Catecholamine-mediated reduction in uterine blood flow after nicotine infusion in the pregnant ewe
57. The maternal and fetal physiologic effects of nicotine
58. Advanced report of final natality statistics, 1993
59. Smoking and drinking behavior before and during pregnancy of married mothers of live-born infants and stillborn infants
60. Prenatal exposure to cannabis: A critical review of effects on growth, development, and behavior
61. A meta-analysis of randomized trials of prenatal smoking cessation interventions
62. Extent of nicotine and continue transfer to the human fetus, placenta and amniotic fluid of smoking mothers
63. Determination of nicotine concentrations in human milk
64. Cigarette smoking and fetal breathing movements
65. Effects of nicotine on human fetal blood flow
66. Correlation of meconium-stained amniotic fluid, early intrapartum PH and Apgar scores as predictors of prenatal outcome
67. Smoking, pregnancy and the fetus
68. Effects of maternal smoking on adverse pregnancy outcomes: Examination of the criteria of causation
69. A study of smoking and pregnancy with special reference to fetal growth
70. A community study of smoking in pregnancy
71. Abruptio placentae and placenta previa: Frequency, perinatal mortality and cigarette smoking
72. Passive and active maternal smoking during pregnancy, as measured by serum cotinine, and postnatal smoke exposure. I. Effects of physical growth at age 5 years [and] II. Effects on neurodevelopment at age 5 years
73. Gross differences observed in the placentas of smokers and non-smokers
74. The effect of smoking in pregnancy on early placental morphology
75. Cigarette smoking during pregnancy and the occurrence of spontaneous abortion and congenital abnormality
76. Maternal smoking and congenital malformations: An epidemiologic study
77. The relationship between maternal smoking and the incidence of congenital anomalies
78. Retrospective and prospective epidemiological studies of 1500 karyotyped spontaneous human abortions
79. Smoking during pregnancy: The dose dependence of birthweight deficits
80. Cigarette smoking and birthweight: Type of cigarette smoked and a possible threshold effect
81. Low birthweight at term and the timing of fetal exposure to maternal smoking
82. Metabolism of nicotine
83. Effects of short-term use of nicotine gum in pregnancy smokers
84. Maternal smoking during pregnancy: Effects on lung function during the first 18 months of life
85. Prevention of pediatric pulmonary problems: The importance of maternal smoking
86. Maternal smoking influences cord serum IgE and IgD levels and increases the risk for subsequent infant allergy
87. Increased blood pressure in neonates and infants whose mothers smoked during pregnancy
88. The effect of passive smoking and tobacco exposure through breast milk on sudden infant death syndrome